Age, Biography and Wiki
Joseph DeSimone was born on 16 May, 1964 in United States. Discover Joseph DeSimone's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 59 years old?
| Popular As | N/A |
| Occupation | N/A |
| Age | 59 years old |
| Zodiac Sign | Taurus |
| Born | 16 May, 1964 |
| Birthday | 16 May |
| Birthplace | United States |
| Nationality | United States |
We recommend you to check the complete list of Famous People born on 16 May. He is a member of famous with the age 59 years old group.
Joseph DeSimone Height, Weight & Measurements
At 59 years old, Joseph DeSimone height not available right now. We will update Joseph DeSimone's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Not Available |
| Sibling | Not Available |
| Children | Not Available |
Joseph DeSimone Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Joseph DeSimone worth at the age of 59 years old? Joseph DeSimone’s income source is mostly from being a successful . He is from United States. We have estimated Joseph DeSimone's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Joseph DeSimone Social Network
Timeline
In recent years DeSimone’s academic research group has been heavily focused on learning how to bring the precision, uniformity and mass production techniques associated with the fabrication of nanoscale features found in the microelectronics industry to the nanomedicine field for the fabrication and delivery of vaccines and therapeutics for the treatment and prevention of diseases. Developed in the DeSimone laboratory, the PRINT technology (Particle Replication in Non-Wetting Templates) is central to the group's work.
DeSimone’s academic laboratory and the PRINT technology became a foundation for the Carolina Center for Cancer Nanotechnology Excellence funded by the National Cancer Institute. DeSimone also co-founded Liquidia Technologies in 2004 based on PRINT.
DeSimone was awarded the National Medal of Technology and Innovation, the highest honor in the U.S. for achievements related to technological progress, by President Barack Obama at the White House in May 2016. In 2017, Dr. DeSimone received the 22nd Annual Heinz Award in Technology, the Economy, and Employment.
He is also the recipient of the 2015 Kabiller Prize in Nanoscience and Nanomedicine; the 2014 IRI Medal; the 2014 Dickson Prize in Science; the 2014 American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success; the 2012 Walston Chubb Award for Innovation, presented by Sigma Xi, The Scientific Research Society, to honor and promote creativity in science and engineering; the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce; the 2009 NIH Director's Pioneer Award; the 2009 North Carolina Award, the highest honor the State of North Carolina can bestow to recognize notable achievements of North Carolinians in the fields of Literature, Science, the Fine Arts and Public Service; the 2008 Tar Heel of the Year by the Raleigh News & Observer; the 2007 Collaboration Success Award from the Council for Chemical Research; the 2005 American Chemical Society Award for Creative Invention; the 2002 John Scott Award presented by the Board of Directors of City Trusts, Philadelphia, given to "the most deserving" men and women whose inventions have contributed in some outstanding way to the "comfort, welfare and happiness" of mankind; the 2002 Engineering Excellence Award by DuPont; the 2002 Wallace H. Carothers Award from the Delaware Section of the American Chemical Society; and the 2000 Oliver Max Gardner Award from the University of North Carolina. In 2019, DeSimone received the Wilhelm Exner Medal in Polymer Manufacturing.
DeSimone is a member of the National Academy of Medicine (2014), National Academy of Sciences (2012), and the National Academy of Engineering (2005). He is also a member of the American Academy of Arts and Sciences (2005).
In the 1990s he developed an environmentally friendly manufacturing process that relies on supercritical carbon dioxide instead of water and bio-persistent surfactants for the creation of fluoropolymers or high-performance plastics, such as Teflon. In 2002 DeSimone, along with Dr. Richard Stack, a cardiologist at Duke University, co-founded Bioabsorbable Vascular Solutions (BVS) to commercialize a fully bioabsorbable, drug-eluting stent. BVS was acquired by Guidant in 2003. The technology is now marketed by Abbott Vascular for the treatment of coronary artery disease.
Joseph DeSimone received his BS in Chemistry in 1986 from Ursinus College in Collegeville, Pennsylvania and his Ph.D. in Chemistry in 1990 from Virginia Tech in Blacksburg, Virginia.
Joseph M. DeSimone (born May 16, 1964) is an American chemist, inventor and entrepreneur, best known as the 2008 recipient of the $500,000 Lemelson–MIT Prize and as the co-founder and CEO of Carbon, an American technology company.
